Indicators of mortality in patients who are placed on the heart transplant waiting list because of end-stage heart failure;Son dönem kalp yetersizliǧi nedeniyle kalp nakli bekleme listesine alinan hastalarda mortalite belirleyicileri

Turk Kardiyoloji Dernegi Arsivi

Volumn 33, Issue 3, 2005, Pages 149-154

  Duygu, Hamza ^a   Zoghi, Mehdi ^a   Nalbantgil, Sanem ^a   Yaǧdi, Tahir ^b   Akin, Mustafa ^a   Özbaran, Mustafa ^b   Durmaz, Isa ^b  

^a EGE UNIVERSITY   (Turkey)

^b Kalp Damar Cerrahisi Anabilim Dali   (Turkey)

Author keywords

Death, sudden, cardiac; Electrocardiography; Heart failure, congestive mortality surgery; Heart transplantation; Prognosis; Risk assessment; Time factors; Ventricular function, left; Waiting lists

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; QT DISPERSION; RISK ASSESSMENT; SUDDEN DEATH; SURGICAL PATIENT;

EID: 26644445235     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cowburn PJ, Cleland JG, Coats AJ, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
2. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 1994;24:132-9.
3. Struthers AD. Further defining the role for natriuretic peptide levels in clinical practice. Eur Heart J 1999;20:712-4.
4. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343(8893):327-9.
5. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 2001;20:805-15.
6. Kauffman HM, McBride MA, Graham WK, Wolf JS, Ellison MD, Daily OP. United Network for Organ Sharing Donor Data Update, 1988-1995. Transplant Proc 1997;29:122-4.
7. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
8. Castello R, Fagan L Jr, Lenzen P, Pearson AC, Labovitz AJ. Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 1991;68:1677-80.
9. Mugge A, Daniel WG, Herrmann G, Simon R, Lichtlen PR. Quantification of tricuspid regurgitation by Doppler color flow mapping after cardiac transplantation. Am J Cardiol 1990;66:884-7.
10. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-62.
11. Balk AH, Simoons ML, Meeter K, Mochtar B, Bal E, Verwey HF, et al. Too early for cardiac transplantation-the right decision? Eur Heart J 1992;13:1339-44.
12. McManus RP, O'Hair DP, Beitzinger JM, Schweiger J, Siegel R, Breen TJ, et al. Patients who die awaiting heart transplantation. J Heart Lung Transplant 1993;12:159-72.
13. Schmidinger H. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy? Am J Cardiol 1999;83(5B):151D-157D.
14. Taffet GE, Teasdale TA, Bleyer AJ, Kutka NJ, Luchi RJ. Survival of elderly men with congestive heart failure. Age Ageing 1992;21:49-55.
15. Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 1996;28:1781-8.
16. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-8.
17. O'Connor CM, Anderson SA, Meese RB. Clinical determinants of outcome in advanced heart failure: insights from the PRAISE trial. J Am Coll Cardiol 1997;129:246A.
18. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991;84:40-8.
19. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
20. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996;28:1458-63.
21. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-8.
22. Koga Y, Wada T, Toshima H, Akazawa K, Nose Y. Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy. Heart Vessels 1993;8:37-41.
23. Grigioni F, Carinci V, Boriani G, Bracchetti G, Potena L, Magnani G, et al. Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. J Heart Lung Transplant 2002;21:899-902.
24. Kalra PR, Sharma R, Shamim W, Doehner W, Wensel R, Bolger AP, et al. Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. Int J Cardiol 2002;86:225-31.
25. Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm AJ, et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996;17:258-63.
26. Pinsky DJ, Sciacca RR, Steinberg JS. QT dispersion as a marker of risk in patients awaiting heart transplantation. J Am Coll Cardiol 1997;29:1576-84.
27. de Groote P, Millaire A, Foucher-Hossein C, Nugue O, Marchandise X, Ducloux G, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998;32:948-54.
28. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995;25:1143-53.
29. Juilliere Y, Barbier G, Feldmann L, Grentzinger A, Danchin N, Cherrier F. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. Eur Heart J 1997;18:276-80.
30. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl):17-23.
31. Deng MC, Gradaus R, Hammel D, Weyand M, Gunther F, Kerber S, et al. Heart transplant candidates at high risk can be identified at the time of initial evaluation. Transpl Int 1996;9:38-45.